Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Pfizer’s Daurismo to treat acute myeloid leukaemia

pharmaceutical-technologyNovember 25, 2018

Tag: myeloid leukaemia , Pfizer’s Daurismo , FDA , myeloid leukaemia

PharmaSources Customer Service